RxDoctor Payments DataLook up a doctor →

Jacqueline Vuky

Hematology & Oncology · Portland, ORNPI 1851462998

Payments from drug & device makers

$5,448,385in general payments, 2019–2025

Across 728 payments — averaging $7484.04 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Merck$1.5M
  • Exelixis Inc.$1M
  • Eli Lilly$934K
  • Astrazeneca UK Limited$428K
  • E.r. Squibb & Sons, L.L.C.$254K
  • Eisai Inc.$243K
  • plus $1.1M from 14 others
$5,822in research payments, 2019–2025

Across 3 payments — averaging $1940.80 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$5K
  • F. Hoffmann-la Roche AG$894

General payments by program year

19
20
21
22
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$5,448,385 in reported general payments places this provider in the 95th percentile of 112 hematology & oncology providers in Oregon.

See all hematology & oncology providers in Oregon

Other hematology & oncology in Portland

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →